Login
Emergent BioSolutions Inc logo

Emergent BioSolutions Inc

emergentbiosolutions.com

Emergent BioSolutions (NYSE: EBS) is a specialty biopharmaceutical and contract development and manufacturing company focused on public health threats, including chemical, biological, radiological, and nuclear threats, as well as infectious diseases. The filing excerpts provided do not contain sufficient detail to characterize specific revenue streams, segment breakdowns, product revenue figures, customer concentration, geographic mix, or competitive positioning. All such fields have been left empty or omitted in accordance with source-grounding rules. Only information directly supported by the provided filing excerpts has been included in this description.

Financial Snapshot

Revenue
TTM
$770.2M
Gross Margin
TTM
54.55%
Net Income
TTM
-$176.8M
Current Assets
2026 Q2
Current Liabilities
2026 Q2
Current Ratio
2026 Q2
542.35%
Total Assets
2026 Q2
Total Liabilities
2026 Q2
Book Value
2026 Q2
$341.4M
Cash
2026 Q2
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
$31.90M

Stock Price

Loading...
Market Cap: $260.47 Million

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support